New BOPA forum for Clinical Trials
We are pleased to share that a new national forum for oncology and haematology clinical trials pharmacy is now live for BOPA members. As many of you know, working in…
Read article
BOPA AI Blog: Finding the Balance – Responsible AI Use for Students
As artificial intelligence (AI) becomes increasingly common in clinical settings, it is also being adopted by pharmacy students to help streamline their experience at university. When used appropriately, AI can…
BOPA welcomes Royal Pharmaceutical Society appointment of Justine Scanlan as Director of Pharmacy
The Royal Pharmaceutical Society (RPS) today (2nd April 2026) announced the appointment of Dr Justine Scanlan FRPharmS as its new Director of Pharmacy, a key leadership role as the organisation…
BOPA Education and Training Webinar: Clinical AI in the NHS
Helena Langford is a Fellow in Clinical AI and a Clinical Informatics Pharmacist at University Hospitals Bristol and Weston NHS Foundation Trust, with several years of experience in clinical informatics.…
Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)
First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…
ISOPP 2026 International Symposium – Program & Important Information Announcement
A global community of oncology pharmacy practitioners striving to advance cancer care Please support the Symposium by attending plenary sessions, asking questions to the live speakers, joining in the…
Workshop Exploring Support for Patients with Advanced Cancer in Primary Care
On behalf of CASPC, We would like to invite you to an interactive workshop at the Christe Hospital, Manchester, on 23rd April 5.30-8pm (please see attached flyer), to explore support…
Closing the Gap: Bridging Oral Mucositis Guidelines and Clinical Reality
Welcome to our lunchtime online event where we’ll delve into the clinical reality of oral mucositis. Join us as we explore new approaches to care for this common side effect…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
Celebrating Success in the BOPA Immunotherapy Group
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…
Celebrating Black History Month – Celebrating Excellence with Gisela Abbam
In celebration of Black History Month, the Kingston University BAME staff network is excited to invite you to an inspiring session with Gisela Abbam, Chair of the General Pharmaceutical Council (GPhC). Gisela…
AI in Cancer Pharmacy: The Guardrails Keeping Patients Safe
Introduction Artificial intelligence is increasingly becoming part of routine clinical practice in cancer services. From clinical documentation to decision support, AI offers new opportunities to enhance patient care and streamline…